Alpern E R, Alessandrini E A, Bell L M, Shaw K N, McGowan K L
Division of Emergency Medicine, Children's Hospital of Philadelphia, Pennsylvania 19104, USA.
Pediatrics. 2000 Sep;106(3):505-11. doi: 10.1542/peds.106.3.505.
To evaluate selected characteristics of occult bacteremia in the post-Haemophilus influenzae type b (HIB) vaccine era.
A retrospective cohort study was performed involving 5901 children 2 to 24 months old with fever >/=39.0 degrees C evaluated with a blood culture at an urban tertiary care children's hospital emergency department (ED) between February 1993 and June 1996. Patients were excluded if immune-suppressed, diagnosed with a focal infection, evaluated by lumbar puncture, or admitted to the hospital during initial evaluation. Prevalence of occult bacteremia, distribution of current pathogenic organisms, and time to positive culture in a continuously monitored system were determined. All patients with cultures positive for pathogenic bacteria were reevaluated and serious adverse outcomes were documented.
The prevalence of occult bacteremia was 1.9% (95% confidence interval: 1.5%-2.3%). Streptococcus pneumoniae accounted for 82.9% of all pathogens and H influenzae was not a causative organism in this cohort. The mean time to positive culture was significantly shorter for pathogens compared with contaminants (14.9 hours vs 31.1 hours). A culture that was positive in </=18 hours was 13.0 (6.3-26. 6) times more likely to contain a pathogen than a contaminant. The average time from positive culture notification to reevaluation in the ED was 10.6 hours and over half of the patients recalled to the ED for positive cultures were admitted to the hospital. Of patients with occult pneumococcal bacteremia, 95.7% had resolution of their bacteremia without the use of parenteral antibiotics. Two patients had serious adverse outcomes. The rate of meningitis or death was. 03% (.004%-.12%). The contamination rate of blood cultures was 2.1% (1.7%-2.5%). Most (85%) of these patients were reevaluated in the ED and more than one third were admitted to the hospital before full identification of the organism.
Prevalence of occult bacteremia in the post-HIB vaccine era is lower than previously reported. S pneumoniae is the most common causative organism and resolves without parenteral antibiotics in the vast majority of cases. Continuously monitoring blood culture systems allow for early identification and can aid in differentiating contaminated from true pathogenic cultures by time to positive culture. Serious adverse outcome is an uncommon result of occult bacteremia. Updated epidemiology and microbiologic technology may impact the evaluation and treatment of children at risk for occult bacteremia.
评估b型流感嗜血杆菌(HIB)疫苗接种时代隐匿性菌血症的特定特征。
进行了一项回顾性队列研究,纳入1993年2月至1996年6月期间在一家城市三级儿童专科医院急诊科(ED)接受血培养评估的5901名2至24个月大、体温≥39.0℃的儿童。如果患者免疫抑制、诊断为局灶性感染、接受了腰椎穿刺评估或在初始评估期间住院,则将其排除。确定隐匿性菌血症的患病率、当前致病微生物的分布以及在持续监测系统中培养阳性的时间。对所有病原菌培养阳性的患者进行重新评估,并记录严重不良结局。
隐匿性菌血症的患病率为1.9%(95%置信区间:1.5%-2.3%)。肺炎链球菌占所有病原体的82.9%,该队列中流感嗜血杆菌不是致病微生物。与污染物相比,病原菌培养阳性的平均时间显著缩短(14.9小时对31.1小时)。培养≤18小时呈阳性的培养物含有病原体的可能性比污染物高13.0(6.3-26.6)倍。从培养阳性通知到在急诊科重新评估的平均时间为10.6小时,因培养阳性被召回急诊科的患者中超过一半住院。在隐匿性肺炎球菌菌血症患者中,95.7%的患者在未使用静脉抗生素的情况下菌血症得到缓解。两名患者出现严重不良结局。脑膜炎或死亡率为0.03%(0.004%-0.12%)。血培养的污染率为2.1%(1.7%-2.5%)。这些患者中的大多数(85%)在急诊科进行了重新评估,超过三分之一的患者在完全鉴定出病原体之前住院。
HIB疫苗接种时代隐匿性菌血症的患病率低于先前报道。肺炎链球菌是最常见的致病微生物,绝大多数情况下无需静脉抗生素即可缓解。持续监测血培养系统有助于早期识别,并可通过培养阳性时间帮助区分污染培养物与真正的致病培养物。严重不良结局是隐匿性菌血症的罕见结果。最新的流行病学和微生物技术可能会影响隐匿性菌血症高危儿童的评估和治疗。